Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 225 | 275 | 75 | 56 | 68 |
| Cost of Goods | 25 | N/A | N/A | N/A | N/A |
| Gross Profit | 200 | 275 | 75 | 56 | 68 |
| Operating Expenses | 2,311 | 0 | 0 | 0 | 0 |
| Operating Income | -2,086 | 275 | 75 | 56 | 68 |
| Interest Expense | 118 | 0 | 0 | 0 | 0 |
| Other Income | 112 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -2,092 | 275 | 75 | 56 | 68 |
| Net Income Continuous | -2,092 | -1,704 | 1,114 | 1,627 | 1,390 |
| Net Income | $-2,092 | $-1,704 | $1,114 | $1,627 | $1,390 |
| EPS Basic Total Ops | -0.50 | -0.59 | 0.50 | 0.56 | 0.54 |
| EPS Basic Continuous Ops | -0.61 | -0.59 | 0.50 | 0.56 | 0.54 |
| EPS Diluted Total Ops | -0.50 | -0.59 | 0.50 | 0.56 | 0.54 |
| EPS Diluted Continuous Ops | -0.61 | -0.59 | 0.50 | 0.56 | 0.54 |
| EBITDA(a) | $-2,022 | $275 | $75 | $56 | $68 |